Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The main objective of this study will be to obtain data on the efficacy of elsiglutide in
preventing Chemotherapy Induced Diarrhea (CID) in patients with colorectal cancer receiving
5-FU based chemotherapy (FOLFOX4 or FOLFIRI regimen) in comparison to placebo.